NeoGenomics, Inc. - Common Stock (NQ:NEO)

17.15 -0.78 (-4.35%)

Delayed Quote Updated: 12:37 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

May 28, 2024

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics Earnings Analysis: Q1 Recap ↗

May 10, 2024

Via Benzinga

Where NeoGenomics Stands With Analysts ↗

April 30, 2024

Via Benzinga

NEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024 ↗

April 30, 2024

NEO stock results show that NeoGenomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

NeoGenomics Reports First Quarter 2024 Results

April 30, 2024

From NeoGenomics, Inc.

Via Business Wire

What 6 Analyst Ratings Have To Say About NeoGenomics ↗

March 18, 2024

Via Benzinga

Evaluating NeoGenomics: Insights From 4 Financial Analysts ↗

February 21, 2024

Via Benzinga

NeoGenomics Announces Senior Leadership Promotions

April 18, 2024

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

April 09, 2024

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

March 27, 2024

From NeoGenomics, Inc.

Via Business Wire

Recap: NeoGenomics Q4 Earnings ↗

February 20, 2024

Via Benzinga

NeoGenomics's Earnings Outlook ↗

February 19, 2024

Via Benzinga

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report

March 20, 2024

From NeoGenomics, Inc.

Via Business Wire

Earnings Scheduled For March 15, 2024 ↗

March 15, 2024

Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million.

Via Benzinga

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference

March 01, 2024

From NeoGenomics, Inc.

Via Business Wire

Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know ↗

February 22, 2024

Via Benzinga

NeoGenomics Stock Surged But Technicals Point To A Pullback ↗

February 22, 2024

NeoGenomics stock price popped sharply this week after the company published strong financial results. It soared to a high of $16.50, its highest point since December 29th. It has soared by more than...

Via Talk Markets

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today? ↗

February 21, 2024

NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith anticipates strong growth, guiding a positive fiscal 2024 outlook with an...

Via Benzinga

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday ↗

February 21, 2024

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

February 21, 2024

Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 21, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

February 21, 2024

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 20, 2024

Via Benzinga

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

February 20, 2024

From NeoGenomics, Inc.

Via Business Wire

Earnings Scheduled For February 20, 2024 ↗

February 20, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

Via Benzinga

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

February 01, 2024

From NeoGenomics, Inc.

Via Business Wire

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

From FN Media Group LLC

Via GlobeNewswire

NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024

January 30, 2024

From NeoGenomics, Inc.

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.